References
- Hellerstedt BA, Pienta KJ. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin. 2002 ; 52 : 154-79. https://doi.org/10.3322/canjclin.52.3.154
- Feldman BJ, Feldman D. The develop- ment of androgenindependent prostate cancer. Nat. Rev. Cancer. 2001 ; 1 : 34-45. https://doi.org/10.1038/35094009
- Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med. 2003 ; 349 : 366-81. https://doi.org/10.1056/NEJMra021562
- Santos AF, Huang H, Tindall DJ. The androgen receptor: a potential target for therapy of prostate cancer. Steroids. 2004 ; 69 : 79-85. https://doi.org/10.1016/j.steroids.2003.10.005
- Srilatha Swami, Aruna V Krishnan, Donna M Peehl, David Feldman. Genistein potentiates the growth inhibitory effects of 1.25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: Role of the direct inhibition of CYP24 enzyme activity. Molecular and Cellular Endocrinology 2005 ; 241 : 49-61. https://doi.org/10.1016/j.mce.2005.05.001
- Brown RL, Haley TL, West KA, Crabb JW. Pseudechetoxin: a peptide blocker of cyclic nucleotide-gated ion channels. Proc Natl Acad Sci USA. 1999 ; 96 : 754-9. https://doi.org/10.1073/pnas.96.2.754
- Sher E, Giovannini F, Boot J. Lang B. Peptide neurotoxins, small-celllung carcinoma andneurological paraneoplastic syndromes. Biochimie. 2000 ; 82 : 927-36. https://doi.org/10.1016/S0300-9084(00)01165-2
- van Lunteren E, Moyer M. Peptide toxin blockers of voltage-sensitive K+ channels: inotropic effects on diaphragm. J Appl Physiol. 1999 ; 3 : 1009-16.
- Park HJ, Lee SH, Son DJ, Oh KW, Kim KH, Song HS, Kim GJ, Oh GT, Yoon DY and Hong JT. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF -kappaB through interaction with the p50 subunit. Arthritis Rheum 2004 ; 50 : 3504-15. https://doi.org/10.1002/art.20626
- Holle L, Song W, Holle E, Wei Y, Wagner T and Yu X. A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo. Int J Oncol. 2003 ; 22 : 93-98.
- Park HJ, Lee YK, Song HS, Kim KJ, Son DJ, Lee JW and Hong JT. Melittin inhibits human prostate cancer cell growth through induction of apoptotic cell death. J Toxicol. Pub. Health. 2006 ; 22(1) : 31-7.
-
HS Lee, HS Song. Bee venom inhibits LNCaP cell proliferation through induction of apoptosis via inactivation of NF -
$\kappa$ B. Journal of acupuncture and moxibustion 2008 ; 25(2) : 59-74. - Dong ju Son, Mi Hee Park, Sang jin Chae et al. Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor KB. Mol Cancer Ther. 2007 ; 6(2) : 675-83. https://doi.org/10.1158/1535-7163.MCT-06-0328
- Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000 ; 21 : 485-95. https://doi.org/10.1093/carcin/21.3.485
- Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Death receptor-induced cell death in prostate cancer. J Cell Biochem, 2004 ; 91 : 70-99. https://doi.org/10.1002/jcb.10707
- Gurumurthy S, Vasudevan KM, Rangnekar VM. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev. 2001 ; 20 : 225-43. https://doi.org/10.1023/A:1015583310759
- Kantoff PW. New agents in the therapy of hormone-refractory patients with prostate cancer. Semin Oncol 1995 ; 22(1 Suppl 1) : 324.
- Sub J, Payvandi F, Edelstein LC et al. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate. 2002 ; 52 : 183-200. https://doi.org/10.1002/pros.10082
- Raj GV, Sekula JA, Guo R, Madden JF, Daaka Y. Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF -kappaB. Prostate. 2004 ; 61 : 105-13. https://doi.org/10.1002/pros.20083
- Syrovets T, Gschwend JE, Buchele B et al. Inhibition of IkappaB kinase activity by acetylswellic acids promotes apoptosis in androgenndependent PC-3 prostate cancer cells in vitro and in vivo. J BioI Chem. 2005 ; 280 : 6170-80.
- Li Y, Sarkar FH. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res. 2002 ; 8 : 2369-77.